MARIA RODRIGUEZ-BARRADAS to Treatment Outcome
This is a "connection" page, showing publications MARIA RODRIGUEZ-BARRADAS has written about Treatment Outcome.
Connection Strength
0.251
-
Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1). J Med Virol. 2025 May; 97(5):e70349.
Score: 0.019
-
Integrated Stepped Alcohol Treatment With Contingency Management for Unhealthy Alcohol Use Among People With HIV: A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2025 01 01; 98(1):72-81.
Score: 0.019
-
Clinical Outcomes After Acute Coronary Syndromes or Revascularization Among People Living With HIV: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 05 01; 7(5):e2411159.
Score: 0.018
-
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial. Lancet Infect Dis. 2023 04; 23(4):484-495.
Score: 0.016
-
COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study. JMIR Public Health Surveill. 2021 01 22; 7(1):e24502.
Score: 0.014
-
Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial. Addict Sci Clin Pract. 2020 07 29; 15(1):28.
Score: 0.014
-
Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial. J Subst Abuse Treat. 2019 11; 106:97-106.
Score: 0.013
-
Short-term outcomes for lung cancer resection surgery in HIV infection. AIDS. 2019 07 01; 33(8):1353-1360.
Score: 0.013
-
Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial. Lancet HIV. 2019 08; 6(8):e509-e517.
Score: 0.013
-
Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial. Clin Infect Dis. 2017 03 15; 64(6):759-764.
Score: 0.011
-
HIV patient and provider feedback on a telehealth collaborative care for depression intervention. AIDS Care. 2017 03; 29(3):290-298.
Score: 0.011
-
The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients. Contemp Clin Trials. 2017 01; 52:80-90.
Score: 0.011
-
Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America. J Int AIDS Soc. 2016; 19(1):20684.
Score: 0.010
-
Cost-Effectiveness of Collaborative Care for Depression in HIV Clinics. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):377-85.
Score: 0.010
-
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med. 2014 Mar 18; 160(6):369-79.
Score: 0.009
-
Photo quiz. To scan or not to scan? Clin Infect Dis. 2013 Apr; 56(7):1003, 1052-3.
Score: 0.008
-
Examining the link between patient satisfaction and adherence to HIV care: a structural equation model. PLoS One. 2013; 8(1):e54729.
Score: 0.008
-
Patient-reported symptoms on the antiretroviral regimen efavirenz/emtricitabine/tenofovir. AIDS Patient Care STDS. 2012 Jun; 26(6):312-9.
Score: 0.008
-
Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med. 2011 Jan 10; 171(1):23-31.
Score: 0.007
-
Time to depression treatment in primary care among HIV-infected and uninfected veterans. J Gen Intern Med. 2010 Jul; 25(7):656-62.
Score: 0.007
-
Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence? Clin Infect Dis. 2009 Mar 15; 48(6):822-6.
Score: 0.006
-
Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS. 2007 Jul 31; 21(12):1579-89.
Score: 0.006